Angela De Luca

Medicine & Life Sciences

1. Osteosarcoma 100%
2. MicroRNAs 79%
3. Bone and Bones 50%
4. Multiple Myeloma 44%
5. Ritonavir 44%
6. Bone Diseases 42%
7. Osteogenesis 42%
8. Exosomes 41%
9. Osteoporosis 38%
10. Ellis-Van Creveld Syndrome 30%
11. Bone Resorption 29%
12. Circulating MicroRNA 28%
13. HIV-1 28%
14. Ultrasonic Waves 26%
15. Tumor Microenvironment 26%
16. Darunavir 26%
17. Atazanavir Sulfate 25%
18. Therapeutics 25%
19. Cell Line 25%
20. HIV 25%
21. Product Packaging 24%
22. Mesenchymal Stem Cells 24%
23. Lamivudine 21%
24. Osteoclasts 20%
25. Extracellular Vesicles 20%
26. Untranslated RNA 19%
27. Neoplasms 19%
28. Epigenomics 19%
29. Osteoblasts 18%
30. Treatment Failure 15%
31. Homeostasis 15%
32. Neoplasm Metastasis 13%
33. dolutegravir 13%
34. p31 integrase protein, Human immunodeficiency virus 1 13%
35. Integrase Inhibitors 13%
36. Osteoarthritis 12%
37. Raltegravir Potassium 12%
38. RNA 12%
39. Metabolic Bone Diseases 12%
40. Lopinavir 12%
41. Viral Load 12%
42. Flavonoids 11%
43. Viremia 11%
44. Musculoskeletal Diseases 11%
45. Proteins 11%
46. Polyphenols 11%
47. Hypoxia-Inducible Factor 1 10%
48. Terpenes 10%
49. Connexin 43 10%
50. Cytoskeletal Proteins 10%